Y. Kobayashi

发表

S-1 and irinotecan plus bevacizumab versus mFOLFOX6 or CapeOX plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer (TRICOLORE): a randomized, open-label, phase III, noninferiority trial

C. Ishioka, H. Shimodaira, S. Morita, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

REVERCE: a randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for previously treated metastatic colorectal cancer patients

E. Oki, T. Yamanaka, J. Furuse, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

An activating ALK gene mutation in ALK IHC-positive/FISH-negative nonsmall-cell lung cancer.

T. Mitsudomi, S. Tomida, M. D. De Velasco, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

REVERCE: a randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for previously treated metastatic colorectal cancer patients.

E. Oki, T. Yamanaka, J. Furuse, 2019 .

Genetic features of pulmonary adenocarcinoma presenting with ground-glass nodules: the differences between nodules with and without growth.

Y. Yatabe, T. Mitsudomi, Y. Sakao, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Genetic features of pulmonary adenocarcinoma presenting with ground-glass nodules: the differences between nodules with and without growth.

Y. Yatabe, T. Mitsudomi, Y. Sakao, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

REVERCE: Randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for metastatic colorectal cancer patients previously treated with fluoropyrimidine, oxaliplatin, and irinotecan: Quality of life analysis.

E. Oki, T. Yamanaka, J. Furuse, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

A phase I/II study of S-1 plus cisplatin alternating with S-1 plus docetaxel in patients with advanced gastric cancer (AGC).

S. Kajiura, S. Sumi, A. Hosokawa, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.